A Miniaturized Fluidic Chip For Long-term Maintenance and Impedance Monitoring of
A Miniaturized Fluidic Chip For Long-term Maintenance and Impedance Monitoring of
批准号:
8124488
负责人:
Tahmina Jafar Naqvi
金额:
$16.5万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-05-18 至 2013-04-30
关键词:
AgricultureAntibodiesAutomationBiologicalBiological AssayBioluminescenceBiosensorBuffersCarbon DioxideCell Culture SystemCell Culture TechniquesCell LineCell SurvivalCell physiologyCellsChemicalsClinicalClinics and HospitalsCollaborationsConditioned Culture MediaCulture MediaDetectionDevelopmentDevicesDiagnosticDimensionsDisadvantagedDrug IndustryEnvironmentEnvironmental MonitoringEventFoodFood SafetyFood SupplyGrowthHealthHumanIn VitroIndustryLifeLongevityLow-Density LipoproteinsMaintenanceMammalian CellMarketingMeasurementMeasuresMethodsMicrofabricationMicrofluidicsMiniaturizationMonitorNucleic AcidsPathogen detectionPermeabilityPharmacologic SubstancePhysiologicalPlayPopulationProcessPublic HealthRoleScreening procedureSignal TransductionSiteSlideSmall Business Innovation Research GrantSystemTechnologyTimeToxic effectToxicant exposureToxinValidationWaterWater SupplyWeightbasebiodefensebiosecuritycell typecostcost effectivedesigndrug discoveryelectric impedanceenzyme activityhigh throughput screeningimprovedinnovationluminescencemicroorganism toxinminiaturizeoperationpathogenpolycarbonateportabilityresponsesensortooltoxicanttoxicant screeninguptake
中文摘要
描述(由申请人提供):该SBIR项目旨在通过延长培养的哺乳动物细胞的活力来开发小型化的基于细胞的生物传感器,以实现低成本、便携性和延长的保质期。我们将通过创建尺寸比目前可用的电电池基板阻抗传感(ECIS)系统小约100倍的微芯片来展示我们当前技术的优势。由于更小的芯片尺寸,将大大降低成本和介质存储和更换量。我们还将通过更换为适当的CO2非依赖性缓冲系统来优化培养基条件,以延长所选哺乳动物细胞系在环境条件下至少45天的活力。此外,我们将结合多参数细胞传感,以改善毒性检测,而不是使用单一的细胞阻抗参数。这种小的,低成本的系统具有延长的保质期将具有显着的价值,作为一个便携式现场设备筛选毒物和病原体在临床环境中,食品和供水,以及在高通量应用中的目标验证制药工业。该SBIR提案的具体目标包括:1)设计和制造用于阻抗测量的小型化电路,2)设计和制造不透CO2的微流体卡,3)在不依赖CO2的培养基中培养细胞并监测在微流体环境中45天期间和之后的阻抗变化,和4)用至少三种已知的化学毒物评价所开发的微流体卡的毒物响应性,并与市售ECIS系统进行比较。
公共卫生相关性:基于细胞的生物传感器(Cell-based biosensors,CBB)在检测病原体、毒素或生物活性化合物方面具有巨大的潜力,可用于临床、制药、环境、生物安全和高通量筛选(High-throughput screening,HTS)等领域。在筛选食品和农产品时尽早使用这些标准将是有益的,因为食品、水和农业的安全对公共卫生和经济有重大影响,因而是最令人关切的问题。哺乳动物细胞为基础的生物传感器正在开发中,在诊所或医院现场使用,作为生物防御应用和环境监测的第一反应。目前,这些基于哺乳动物细胞的系统是昂贵的,因为它们的保质期短,因为哺乳动物细胞在没有大的外部培养基递送和维持系统的情况下最难以保持培养数天。低保存期和高维护成本限制了在现场操作和HTP筛选应用中使用其他高效筛选工具。因此,需要取得重大进展来改进目前的系统。微制造、微流体和细胞培养的集成有能力通过制造小型、便携且具有成本效益的传感器来改变当前的情况,因为制造它们所需的原材料较少。此外,小尺寸降低了培养基和培养物的要求。此外,优化实地使用的介质条件将使用户能够使用这些介质。
英文摘要
DESCRIPTION (provided by applicant): This SBIR project is designed to develop miniaturized cell-based biosensors for low cost, portability and enhanced shelf life by extending the viability of the cultured mammalian cells. We will demonstrate the benefit of our current technology by creating micro-chips with approximately 100 times smaller dimensions than the currently available Electrical Cell- Substrate Impedance Sensing (ECIS) systems. Because of the smaller chip dimensions there will be significant reduction in cost and media storage and replacement volumes. We will also optimize the media conditions by changing to appropriate CO2- independent buffer systems to extend the viability of the chosen mammalian cell line for a period of at least 45 days under ambient conditions. Moreover, we will incorporate multiparameter cellular sensing for improved toxicity detection over using a single parameter of cellular impedance. This small, low cost system with extended shelf life will have significant value as a portable field device for screening toxicants and pathogens in clinical settings, food and water supplies, as well as in high throughput applications for target validation in pharmaceutical industry. Specific aims of this SBIR proposal include: 1) Design and manufacture miniaturized circuits for impedance measurements, 2) Design and manufacture CO2- impervious microfluidic cards, 3) Propagate cells in CO2- independent media and monitor change in impedance during and after 45 days in a microfluidic environment, and 4) Evaluate toxicant responsiveness of the developed microfluidic card with at least three known chemical toxicants and compare with commercially available ECIS systems.
PUBLIC HEALTH RELEVANCE: Cell-based biosensors (CBBs) have tremendous potential to be used as efficient, reliable and sensitive tools for the detection of pathogens, toxins or bioactive compounds for clinical, pharmaceutical, environmental, biosecurity and high-throughput screening (HTS) applications. Their early use in the screening of food and agriculture products would be beneficial as the safety of food, water and agriculture is of ultimate concern because of its significant impact on public health and economy. Mammalian cell-based biosensors are being developed for on-site use in clinics or hospitals as a first response in biodefense applications and for environmental monitoring. Currently these mammalian cell based systems are expensive because of their short shelf life, as mammalian cells are most difficult to keep in culture for several days without large external media delivery and maintenance systems. The low shelf life and high maintenance cost limits the use of an otherwise highly effective screening tool in field operations and in HTP screening applications. Therefore, significant advances are required to improve the present systems. The integration of microfabrication, microfluidics and cell culture have the ability to change the current scenario by fabricating sensors that are small, portable and cost effective because less raw material is required to fabricate them. In addition, the small size reduces the media and culture requirements. Moreover, the optimization of media conditions for field use would make them accessible to the user.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Comparative developmental and phenotypic properties of altered hepatocyte foci and hepatic tumors in rats.
大鼠肝细胞灶和肝肿瘤改变的发育和表型特性的比较。
DOI:
--
发表时间:
1988
期刊:
Cancer research
影响因子:
11.2
作者:
[Peraino,C, Carnes,BA, Stevens,FJ, Staffeldt,EF, Russell,JJ, Prapuolenis,A, Blomquist,JA, Vesselinovitch,SD, Maronpot,RR]
通讯作者:
Maronpot,RR
Effects of separate and combined treatments with gamma radiation and diethylnitrosamine in neonatal rats on the induction of altered hepatocyte foci and hepatic tumors.
伽马射线和二乙基亚硝胺单独和联合治疗对新生大鼠肝细胞病灶改变和肝肿瘤诱导的影响。
DOI:
10.1093/carcin/8.4.599
发表时间:
1987
期刊:
Carcinogenesis
影响因子:
4.7
作者:
[Peraino,C, Grdina,DJ, Staffeldt,EF, Russell,JJ, Prapuolenis,A, Carnes,BA]
通讯作者:
Carnes,BA
Evidence for growth heterogeneity among foci with different phenotypes in the population of altered hepatocyte foci induced by a single neonatal treatment with carcinogen.
单一新生儿致癌剂治疗诱导的改变肝细胞病灶群体中不同表型病灶之间生长异质性的证据。
DOI:
10.1093/carcin/7.2.191
发表时间:
1986
期刊:
Carcinogenesis
影响因子:
4.7
作者:
[Peraino,C, Carnes,BA, Stevens,FJ]
通讯作者:
Stevens,FJ
Effects of rat strain, diet composition, and phenobarbital on hepatic gamma-glutamyl transpeptidase histochemistry and on the induction of altered hepatocyte foci and hepatic tumors by diethylnitrosamine.
大鼠品系、饮食成分和苯巴比妥对肝γ-谷氨酰转肽酶组织化学以及二乙基亚硝胺诱导改变的肝细胞病灶和肝肿瘤的影响。
DOI:
--
发表时间:
1987
期刊:
Cancer research
影响因子:
11.2
作者:
[Russell,JJ, Staffeldt,EF, Wright,BJ, Prapuolenis,A, Carnes,BA, Peraino,C]
通讯作者:
Peraino,C
Phenotypically selective promotion of diethylnitrosamine-initiated altered hepatocyte foci by dietary phenobarbital or a topically applied coal-derived organic mixture in male and female rats.
在雄性和雌性大鼠中,通过饮食苯巴比妥或局部应用煤衍生的有机混合物,对二乙基亚硝胺引发的肝细胞病灶改变进行表型选择性促进。
DOI:
10.1016/0304-3835(87)90155-8
发表时间:
1987
期刊:
Cancer letters
影响因子:
9.7
作者:
[Peraino,C, Haugen,DA, Carnes,BA, ReillyJr,CA, Springer,DL, Mahlum,DD]
通讯作者:
Mahlum,DD
共 6 条
海外基金